These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28608759)

  • 1. Challenges in secondary prevention after acute myocardial infarction: A call for action.
    Piepoli MF; Corrà U; Dendale P; Frederix I; Prescott E; Schmid JP; Cupples M; Deaton C; Doherty P; Giannuzzi P; Graham I; Hansen TB; Jennings C; Landmesser U; Marques-Vidal P; Vrints C; Walker D; Bueno H; Fitzsimons D; Pelliccia A
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):299-310. PubMed ID: 28608759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in secondary prevention after acute myocardial infarction: A call for action.
    Piepoli MF; Corrà U; Dendale P; Frederix I; Prescott E; Schmid JP; Cupples M; Deaton C; Doherty P; Giannuzzi P; Graham I; Hansen TB; Jennings C; Landmesser U; Marques-Vidal P; Vrints C; Walker D; Bueno H; Fitzsimons D; Pelliccia A
    Eur J Prev Cardiol; 2016 Dec; 23(18):1994-2006. PubMed ID: 27600690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in secondary prevention after acute myocardial infarction: A call for action.
    Piepoli MF; Corrà U; Dendale P; Frederix I; Prescott E; Schmid JP; Cupples M; Deaton C; Doherty P; Giannuzzi P; Graham I; Hansen TB; Jennings C; Landmesser U; Marques-Vidal P; Vrints C; Walker D; Bueno H; Fitzsimons D; Pelliccia A
    Eur J Cardiovasc Nurs; 2017 Jun; 16(5):369-380. PubMed ID: 28565965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.
    Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE
    Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.
    Urbinati S; Olivari Z; Gonzini L; Savonitto S; Farina R; Del Pinto M; Valbusa A; Fantini G; Mazzoni A; Maggioni AP;
    Eur J Prev Cardiol; 2015 Dec; 22(12):1548-56. PubMed ID: 25452625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cardiac rehabilitation in secondary prevention after coronary events.
    Peersen K; Munkhaugen J; Gullestad L; Liodden T; Moum T; Dammen T; Perk J; Otterstad JE
    Eur J Prev Cardiol; 2017 Sep; 24(13):1360-1368. PubMed ID: 28664773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
    Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
    Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Infarction with Nonobstructive Coronary Arteries: The Importance of Achieving Secondary Prevention Targets.
    Eggers KM; Hadziosmanovic N; Baron T; Hambraeus K; Jernberg T; Nordenskjöld A; Tornvall P; Lindahl B
    Am J Med; 2018 May; 131(5):524-531.e6. PubMed ID: 29287973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
    Shen L; Shah BR; Nam A; Holmes D; Alexander KP; Bhatt DL; Ho PM; Peterson ED; He B; Roe MT
    Am Heart J; 2014 Jun; 167(6):840-5. PubMed ID: 24890533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors.
    Kaski JC; Fernandez-Berges D
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):185-91. PubMed ID: 18317916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning secondary prevention: Room for improvement.
    Cortés-Beringola A; Fitzsimons D; Pelliccia A; Moreno G; Martín-Asenjo R; Bueno H
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):22-28. PubMed ID: 28618903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial.
    McAlister FA; Majumdar SR; Lin M; Bakal J; Fradette M; Anderson T
    Can J Cardiol; 2014 Dec; 30(12):1627-32. PubMed ID: 25307535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.